Background and aims
Both vascular disease and diabetes type 2 (DM2) decrease cognitive functioning in elderly people. It is uncertain if DM2 affects cognition independent of vascular disease. In patients with symptomatic arterial disease, we studied the effect of DM2 on cognition and identified clinical and radiological determinants for impaired cognition in patients with DM2.
766 patients (mean age 58.8±9.5 years; 108 DM2) with symptomatic arterial disease underwent neuropsychological testing. In 542 patients (77 DM2), volumes of brain tissue, ventricles and white matter lesions were obtained by segmentation of brain MR images. Infarcts were distinguished into small (lacunar) or large (cortical or subcortical).
Patients with arterial disease and DM2 performed worse on neuropsychological tests compared to similar patients without DM2 (adjusted composite z-score: β −0.14 [−0.25 to −0.02]). Insulin treatment, systolic and diastolic blood pressures were significantly associated with cognition in patients with DM2. Large infarcts, global and cortical atrophy on MRI were independently associated with cognition in patients with DM2.
The presence of DM2 in patients with symptomatic arterial disease is associated with decreased cognitive functioning. Insulin treatment, high blood pressure, brain atrophy and large infarcts were determinants for cognitive dysfunction in patients with DM2 and arterial disease.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Journal of the Neurological Sciences
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations.Eur J Pharmacol. Apr 19 2004; 490: 169-175
- Type 2 diabetes mellitus, cognitive impairment and dementia.Diabet Med. Feb 1999; 16: 93-112
- Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes.Diabetes. Apr 2006; 55: 1106-1113
- Factors associated with lower mini mental state examination scores in elderly Japanese diabetes mellitus patients.Neurobiol Aging. Apr 12 2007;
- The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function.J Clin Exp Neuropsychol. Nov 2004; 26: 1044-1080
- Brain imaging in patients with diabetes: a systematic review.Diabetes Care. Nov 2006; 29: 2539-2548
- Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus.Age Ageing. Mar 2007; 36: 164-170
- Second manifestations of ARTerial disease (SMART) study: rationale and design.Eur J Epidemiol. Oct 1999; 15: 773-781
- Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia. Jul 1985; 28: 412-419
- Neuropsychological assessment.Oxford University Press, 2004
- National adult reading test (NART) manual.NFER-Nelson, Windsor1982
- Probabilistic segmentation of white matter lesions in MR imaging.NeuroImage. Mar 2004; 21: 1037-1044
- Probabilistic segmentation of brain tissue in MR imaging.NeuroImage. 2005 Oct 1; 27: 795-804
A.M. Tiehuis, K.L. Vincken, W.P.Th.M. Mali, et al. Automated and visual scoring methods of cerebral white matter hyperintensities; relation with age and cognitive function. Cerebrovasc Dis. 2008;25(1–2):59–66.
- Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes.Diabetologia. Nov 2007; 50: 2388-2397
- NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study.Diabetes Care. Sep 1997; 20: 1388-1395
- Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study.Age Ageing. Jul 2004; 33: 355-361
- Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort.Arch Intern Med. Jun 28 2004; 164: 1327-1333
- Decreased cognitive function in aging non-insulin-dependent diabetic patients.Am J Med. Dec 1984; 77: 1043-1048
- Improving metabolic control leads to better working memory in adults with type 2 diabetes.Diabetes Care. Feb 2006; 29: 345-351
- Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia.Diabetes. Jan 2003; 52: 149-156
- Insulin and neurodegenerative disease: shared and specific mechanisms.Lancet Neurol. Mar 2004; 3: 169-178
- Hyperinsulinemia and risk of Alzheimer disease.Neurology. Oct 12 2004; 63: 1187-1192
- Diabetes mellitus and the risk of dementia: the Rotterdam Study.Neurology. Dec 10 1999; 53: 1937-1942
- Insulin resistance and executive dysfunction in older persons.J Am Geriatr Soc. Oct 2004; 52: 1713-1718
- Insulin and cognitive function in an elderly population. The Rotterdam Study.Diabetes Care. May 1997; 20: 792-795
- Hyperinsulinemia and cognitive decline in a middle-aged cohort.Diabetes Care. 2006 Dec; 29: 2688-2693
- Brain lesions on MRI in elderly patients with type 2 diabetes mellitus.Eur Neurol. 2007; 57: 70-74
- Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT).Diabetes Metab Res Rev. Sep 2006; 22: 376-384
Published online: March 09, 2009
☆Disclosure: The authors report no conflicts of interest.
© 2009 Elsevier B.V. Published by Elsevier Inc. All rights reserved.